Peptide Therapeutics Is Estimated To Witness High Growth

 The peptide therapeutics market is estimated to be valued at US$ 44,386.9 Mn or Mn in 2023 and is expected to exhibit a CAGR of 6.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

peptide therapeutics market

Market Overview:

Peptide therapeutics are molecules composed of two or more amino acids linked in a chain. They are used in a wide range of therapeutic areas such as oncology, metabolic disorders, infectious diseases, cardiovascular disorders, pain management, respiratory diseases due to their high selectivity and affinity. The growing adoption of peptide therapeutics as sustainable treatment options is driving the growth of the market.

Market Dynamics:
The peptide therapeutics market is witnessing robust growth owing to increasing adoption of sustainable treatment options. Peptide therapeutics offer minimally invasive treatment approach and causes fewer side effects. This has led to their preference over conventional small molecule drugs. Growing R&D investments by key players to develop novel peptide drugs is also fueling the market growth. Further, rising prevalence of metabolic disorders and cancer has increased the demand for therapeutic peptides. However, high manufacturing costs and stability issues associated with peptide therapeutics remain a challenge for market players.

SWOT Analysis
Strength: Peptide therapeutics have low toxicity and high specificity. They can easily pass blood vessels and reach target sites in the body. Manufacturers enjoy IP protection for innovative peptides.

Weakness: Production of peptide therapeutics requires specialized and expensive equipment. Rigorous safety and efficacy testing is needed before approval which increases costs. Peptide instability makes storage and transport difficult requiring refrigeration.

Opportunity: Increasing prevalence of chronic diseases like cancer and diabetes present growth opportunities. Rising R&D investments are generating innovative forms of peptide therapies. Growth of generic peptide drugs market post-patent expiry of blockbuster brands.

Threats: Stringent regulations for approval delays market entry. Competition from conventional small-molecule drugs poses pricing pressure. Biosimilars erode sales of patented peptide brands once they lose exclusivity.

Key Takeaways

The Global Peptide Therapeutics Market Size is expected to witness high growth, exhibiting CAGR of 6.6% over the forecast period, due to increasing prevalence of chronic diseases. Peptide therapeutics offer targeted treatment benefits over conventional drugs.

Regional analysis: North America dominates the market currently owing to rising healthcare spending and advanced research infrastructure. Asia Pacific is poised to grow at the fastest pace due to growing medical needs of expanding patient population and government efforts to strengthen healthcare systems.

Key players: Key players operating in the Peptide Therapeutics market are Teva Pharmaceutical Industries Ltd, Novo Nordisk A/S, OPKO Health Inc., Lilly, Hanmi Pharm.Co., Sanofi, Circle Pharma, Pfizer Inc., Novartis AG, PeptiDream Inc., Amgen Inc., AstraZeneca, Bachem Holding AG, CordenPharma International, Ipsen Pharma, Merck KGaA, PolyPeptide Group, Bayer AG.

 

Read more: https://www.rapidwebwire.com/peptide-therapeutics-market-demand-share/

Comments

Post a Comment

Popular posts from this blog

Vegan Yogurt Market is Poised for Growth Driven by Rising Health Consciousness

Image
Vegan yogurt is a dairy-free alternative to conventional yogurt made from plant-based milk such as soy, almond, oat, coconut or rice. It provides similar texture and taste to dairy yogurt but without any animal products.Vegan yogurt offers several health advantages over dairy yogurt as it is devoid of lactose, cholesterol and saturated fats. The growing number of people adopting vegan and flexitarian diets has driven the demand for plant-based dairy alternatives like vegan yogurt. The global vegan yogurt market is estimated to be valued at US$ 4.15 Mn in 2024 and is expected to exhibit a CAGR of 4.2% over the forecast period 2024 to 2031. Key Takeaways Key players- Met Fods, Cocos Organic, Hain Celestial, EasiYo Product Limited, Danone, General Mills Inc., Stonyfield Far, Inc., Daiya Foods Inc.m Good Karma foods, Inc.m Hudson River Foodsm NANCY'S, Kite Hill, COYO Pty lTd., Nush Foods, Chobani, LLC, Barambah Oraganics Pty Ltd., Blue Diamond Growers, Dean Foodsm General Mills Inc...
Read more

Hypoglycemic Drugs Market is Estimated to Witness High Growth Owing to Increasing Prevalence of Diabetes in the Geriatric Population

Image
Hypoglycemic drugs or anti-diabetic drugs are medications used to treat diabetes mellitus by lowering blood glucose levels. Some key hypoglycemic drugs include insulin, sulfonylureas, metformin, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors and GLP-1 receptor agonists. These drugs help control blood sugar levels in diabetics and prevent or delay diabetes-related health complications. The global hypoglycemic drugs market is estimated to be valued at US$ 720.72 Mn in 2023 and is expected to exhibit a CAGR of 4.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: The growth of the global hypoglycemic drugs market is majorly driven by the increasing prevalence of diabetes in the geriatric population globally. As per estimates, around 1 in every 11 people aged 65 years and above have diabetes. Further, the number of people with diabetes in this age group is anticipated to grow from 25.9 million in 2017 to...
Read more

Clinical Trials Rising with Digital Technologies Adoption

Image
 Clinical trials support services play a vital role in assisting sponsors and life science companies to conduct clinical trials in a precise and well-organized manner.These services assist pharmaceutical companies in patient recruitment, data management, site management, and overall clinical trial management. With rising complexities in clinical trials owing to integration of technologies like telehealth and remote patient monitoring, the demand for these support services is growing substantially. The global Clinical Trials Support Services Market is estimated to be valued at US$ 22.38 Bn in 2023 and is expected to exhibit a CAGR of 7.8% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: The growing adoption of digital technologies across clinical trials is a key trend accelerating the growth of the clinical trials support services market. Digital tools like electronic data capture, clinical trial manag...
Read more